No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Wednesday morning, rising 0.18% to 1,370.27 on the S&P Europe Select ADR Index. From continental E
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
European equities traded in the US as American depositary receipts opened the week trending higher late Monday morning, rising 0.62% to 1,375.76 on the S&P Europe Select ADR Index. From continental Eu
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading
European equities traded in the US as American depositary receipts opened the week modestly lower Monday morning, declining 0.23% to 1,353.40 on the S&P Europe Select ADR Index. From continental Europ
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending slightly lower on Wednesday morning, declining 0.12% to 1,372.15 on the S&P Europe Select ADR Index. From continental E
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending moderately higher Tuesday morning rising 0.65% to 1,367.36 on the S&P Europe Select ADR Index. From continental Europe,
Earlier Reported, Everest Medicines' Partner Calliditas Therapeutics Announces US FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (NASDAQ:CALT, Nasdaq Stockholm: CALTX))))) ("Calliditas") announced that the U.S. FDA has g
No Data